Marrone Bio Innovations Inc

MBIICIK 0001441693 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K/A filed May 9, 2022. Sentiment + YoY language diff vs prior year. Read sections →

Signal:Material rewriteFull-doc fallback

Full filing:tone -0.0046Δ-0.001038% similar+916/-351 ¶

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

YoY shift: Neutral

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K. This filing is -0.10pp more bearish than last year's.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Marrone Bio Innovations Inc

Name	Roles	Filings
Wochok Zachary S.	Director	2
Woods Robert A	Director	2
Woolf Stuart	Director	2

Showing 11-13 of 13

Per pagePrevPage 3 of 3

All filings

27 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
Jun 13, 2022	Marrone Pamela G Director	SSale	20,492	$1.1771	$24,121
May 25, 2022	Marrone Pamela G Director	SSale	21,009	$1.148	$24,118
Apr 8, 2022	Lee Lara L Director	Holdings only	-	-	-
Apr 8, 2022	Woolf Stuart Director	Holdings only	-	-	-
Apr 8, 2022	Woods Robert A Director	Holdings only	-	-	-

Showing 1-5 of 27

Per pagePage 1 of 6Next

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value